Do analysts recommend DSY or MTEX?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Big Tree Cloud 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Mannatech 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Which has preferable earnings & valuation, DSY or MTEX?

Mannatech has higher revenue and earnings than Big Tree Cloud. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Big Tree Cloud $2.56M 8.13 -$32.53M N/A N/A Mannatech $107.36M 0.11 -$15.21M -$3.91 N/A

Do analysts recommend MTEX or NHTC?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Mannatech 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Natural Health Trends 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Do analysts rate NAII or MTEX?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Natural Alternatives International 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Mannatech 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Does the media prefer NAII or MTEX?

In the previous week, Mannatech had 3 more articles in the media than Natural Alternatives International. MarketBeat recorded 6 mentions for Mannatech and 3 mentions for Natural Alternatives International. Natural Alternatives International's average media sentiment score of 0.78 beat Mannatech's score of 0.18 indicating that Natural Alternatives International is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Natural Alternatives International 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Mannatech 0 Very Positive mention(s) 0 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Do analysts prefer MTEX or DRMA?

Dermata Therapeutics has a consensus price target of $10.00, indicating a potential upside of 584.93%. Given Dermata Therapeutics' stronger consensus rating and higher possible upside, analysts plainly believe Dermata Therapeutics is more favorable than Mannatech. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Mannatech 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Dermata Therapeutics 1 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00

Does the media favor MTEX or DRMA?

In the previous week, Mannatech had 2 more articles in the media than Dermata Therapeutics. MarketBeat recorded 6 mentions for Mannatech and 4 mentions for Dermata Therapeutics. Mannatech's average media sentiment score of 0.18 beat Dermata Therapeutics' score of 0.03 indicating that Mannatech is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Mannatech 0 Very Positive mention(s) 0 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Dermata Therapeutics 0 Very Positive mention(s) 2 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Do analysts recommend SNYR or MTEX?

Synergy CHC currently has a consensus price target of $6.25, suggesting a potential upside of 6,168.81%. Given Synergy CHC's stronger consensus rating and higher possible upside, equities research analysts plainly believe Synergy CHC is more favorable than Mannatech. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Synergy CHC 1 Sell rating(s) 1 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.25 Mannatech 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Is SNYR or MTEX more profitable?

Mannatech has a net margin of -6.90% compared to Synergy CHC's net margin of -60.02%. Synergy CHC's return on equity of 0.00% beat Mannatech's return on equity. Company Net Margins Return on Equity Return on Assets Synergy CHC -60.02% N/A -30.30% Mannatech -6.90% -2,383.34% -24.43%

Trading of Mannatech was halted at 02:22 PM EST due to "LULD Pause".

Mannatech (MTEX) Competitors

$6.25 +0.10 (+1.63%)

As of 02:50 PM Eastern

Compare

MTEX vs. DSY, NHTC, NAII, DRMA, and SNYR

Should you buy Mannatech stock or one of its competitors? Mannatech's main competitors and comparable companies include Big Tree Cloud (DSY), Natural Health Trends (NHTC), Natural Alternatives International (NAII), Dermata Therapeutics (DRMA), and Synergy CHC (SNYR). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "personal care products" industry.

How does Mannatech compare to Big Tree Cloud?

Big Tree Cloud (NASDAQ:DSY) and Mannatech (NASDAQ:MTEX) are both small-cap consumer staples companies, but which is the better investment? We will contrast the two companies based on the strength of their analyst recommendations, risk, institutional ownership, profitability, earnings, dividends, media sentiment and valuation.

Mannatech has higher revenue and earnings than Big Tree Cloud.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Big Tree Cloud	$2.56M	8.13	-$32.53M	N/A	N/A
Mannatech	$107.36M	0.11	-$15.21M	-$3.91	N/A

In the previous week, Mannatech had 5 more articles in the media than Big Tree Cloud. MarketBeat recorded 6 mentions for Mannatech and 1 mentions for Big Tree Cloud. Big Tree Cloud's average media sentiment score of 1.87 beat Mannatech's score of 0.18 indicating that Big Tree Cloud is being referred to more favorably in the media.

Company	Overall Sentiment
Big Tree Cloud	Very Positive
Mannatech	Neutral

60.2% of Big Tree Cloud shares are owned by institutional investors. Comparatively, 13.0% of Mannatech shares are owned by institutional investors. 34.1% of Big Tree Cloud shares are owned by insiders. Comparatively, 47.5% of Mannatech shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Big Tree Cloud	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Mannatech	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Big Tree Cloud has a beta of 0.6, suggesting that its stock price is 40% less volatile than the broader market. Comparatively, Mannatech has a beta of 0.73, suggesting that its stock price is 27% less volatile than the broader market.

Big Tree Cloud has a net margin of 0.00% compared to Mannatech's net margin of -6.90%. Big Tree Cloud's return on equity of 0.00% beat Mannatech's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Big Tree Cloud	N/A	N/A	N/A
Mannatech	-6.90%	-2,383.34%	-24.43%

Summary

Big Tree Cloud beats Mannatech on 6 of the 11 factors compared between the two stocks.

How does Mannatech compare to Natural Health Trends?

Mannatech (NASDAQ:MTEX) and Natural Health Trends (NASDAQ:NHTC) are both small-cap consumer staples companies, but which is the better business? We will compare the two companies based on the strength of their media sentiment, institutional ownership, valuation, risk, analyst recommendations, profitability, dividends and earnings.

13.0% of Mannatech shares are owned by institutional investors. Comparatively, 10.1% of Natural Health Trends shares are owned by institutional investors. 47.5% of Mannatech shares are owned by insiders. Comparatively, 12.9% of Natural Health Trends shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Mannatech	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Natural Health Trends	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Natural Health Trends has a net margin of -4.51% compared to Mannatech's net margin of -6.90%. Natural Health Trends' return on equity of -8.00% beat Mannatech's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Mannatech	-6.90%	-2,383.34%	-24.43%
Natural Health Trends	-4.51%	-8.00%	-4.58%

In the previous week, Mannatech had 5 more articles in the media than Natural Health Trends. MarketBeat recorded 6 mentions for Mannatech and 1 mentions for Natural Health Trends. Natural Health Trends' average media sentiment score of 1.90 beat Mannatech's score of 0.18 indicating that Natural Health Trends is being referred to more favorably in the news media.

Company	Overall Sentiment
Mannatech	Neutral
Natural Health Trends	Very Positive

Natural Health Trends has lower revenue, but higher earnings than Mannatech. Natural Health Trends is trading at a lower price-to-earnings ratio than Mannatech, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Mannatech	$107.36M	0.11	-$15.21M	-$3.91	N/A
Natural Health Trends	$39.78M	0.39	-$880K	-$0.16	N/A

Mannatech has a beta of 0.73, suggesting that its stock price is 27% less volatile than the broader market. Comparatively, Natural Health Trends has a beta of 0.92, suggesting that its stock price is 8% less volatile than the broader market.

Mannatech pays an annual dividend of $0.20 per share and has a dividend yield of 3.2%. Natural Health Trends pays an annual dividend of $0.40 per share and has a dividend yield of 22.1%. Mannatech pays out -5.1% of its earnings in the form of a dividend. Natural Health Trends pays out -250.0% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Natural Health Trends is clearly the better dividend stock, given its higher yield and lower payout ratio.

Summary

Natural Health Trends beats Mannatech on 10 of the 15 factors compared between the two stocks.

How does Mannatech compare to Natural Alternatives International?

Natural Alternatives International (NASDAQ:NAII) and Mannatech (NASDAQ:MTEX) are both small-cap consumer staples companies, but which is the superior stock? We will contrast the two businesses based on the strength of their analyst recommendations, earnings, valuation, risk, institutional ownership, profitability, media sentiment and dividends.

Natural Alternatives International has higher revenue and earnings than Mannatech. Mannatech is trading at a lower price-to-earnings ratio than Natural Alternatives International, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Natural Alternatives International	$129.86M	0.10	-$13.57M	-$2.39	N/A
Mannatech	$107.36M	0.11	-$15.21M	-$3.91	N/A

Mannatech has a net margin of -6.90% compared to Natural Alternatives International's net margin of -10.13%. Natural Alternatives International's return on equity of -12.21% beat Mannatech's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Natural Alternatives International	-10.13%	-12.21%	-5.30%
Mannatech	-6.90%	-2,383.34%	-24.43%

In the previous week, Mannatech had 3 more articles in the media than Natural Alternatives International. MarketBeat recorded 6 mentions for Mannatech and 3 mentions for Natural Alternatives International. Natural Alternatives International's average media sentiment score of 0.78 beat Mannatech's score of 0.18 indicating that Natural Alternatives International is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Natural Alternatives International	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Mannatech	0 Very Positive mention(s)	0 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

32.4% of Natural Alternatives International shares are owned by institutional investors. Comparatively, 13.0% of Mannatech shares are owned by institutional investors. 20.8% of Natural Alternatives International shares are owned by insiders. Comparatively, 47.5% of Mannatech shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

Natural Alternatives International has a beta of 0.36, indicating that its stock price is 64% less volatile than the broader market. Comparatively, Mannatech has a beta of 0.73, indicating that its stock price is 27% less volatile than the broader market.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Natural Alternatives International	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Mannatech	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Summary

Natural Alternatives International beats Mannatech on 8 of the 13 factors compared between the two stocks.

How does Mannatech compare to Dermata Therapeutics?

Mannatech (NASDAQ:MTEX) and Dermata Therapeutics (NASDAQ:DRMA) are both small-cap consumer staples companies, but which is the superior stock? We will contrast the two businesses based on the strength of their profitability, analyst recommendations, institutional ownership, media sentiment, risk, valuation, earnings and dividends.

Dermata Therapeutics has a consensus price target of $10.00, indicating a potential upside of 584.93%. Given Dermata Therapeutics' stronger consensus rating and higher possible upside, analysts plainly believe Dermata Therapeutics is more favorable than Mannatech.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Mannatech	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Dermata Therapeutics	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

Mannatech has a beta of 0.73, meaning that its stock price is 27% less volatile than the broader market. Comparatively, Dermata Therapeutics has a beta of 0.66, meaning that its stock price is 34% less volatile than the broader market.

Dermata Therapeutics has lower revenue, but higher earnings than Mannatech. Mannatech is trading at a lower price-to-earnings ratio than Dermata Therapeutics, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Mannatech	$107.36M	0.11	-$15.21M	-$3.91	N/A
Dermata Therapeutics	N/A	N/A	-$7.56M	-$4.39	N/A

Dermata Therapeutics has a net margin of 0.00% compared to Mannatech's net margin of -6.90%. Dermata Therapeutics' return on equity of -166.66% beat Mannatech's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Mannatech	-6.90%	-2,383.34%	-24.43%
Dermata Therapeutics	N/A	-166.66%	-130.13%

In the previous week, Mannatech had 2 more articles in the media than Dermata Therapeutics. MarketBeat recorded 6 mentions for Mannatech and 4 mentions for Dermata Therapeutics. Mannatech's average media sentiment score of 0.18 beat Dermata Therapeutics' score of 0.03 indicating that Mannatech is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Mannatech	0 Very Positive mention(s)	0 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Dermata Therapeutics	0 Very Positive mention(s)	2 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

13.0% of Mannatech shares are held by institutional investors. Comparatively, 8.7% of Dermata Therapeutics shares are held by institutional investors. 47.5% of Mannatech shares are held by insiders. Comparatively, 21.9% of Dermata Therapeutics shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

Summary

Mannatech beats Dermata Therapeutics on 8 of the 15 factors compared between the two stocks.

How does Mannatech compare to Synergy CHC?

Synergy CHC (NASDAQ:SNYR) and Mannatech (NASDAQ:MTEX) are both small-cap consumer staples companies, but which is the better stock? We will compare the two businesses based on the strength of their profitability, earnings, dividends, media sentiment, risk, valuation, institutional ownership and analyst recommendations.

13.0% of Mannatech shares are held by institutional investors. 32.9% of Synergy CHC shares are held by company insiders. Comparatively, 47.5% of Mannatech shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Synergy CHC has a beta of -0.14, meaning that its share price is 114% less volatile than the broader market. Comparatively, Mannatech has a beta of 0.73, meaning that its share price is 27% less volatile than the broader market.

Synergy CHC has higher earnings, but lower revenue than Mannatech. Mannatech is trading at a lower price-to-earnings ratio than Synergy CHC, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Synergy CHC	$30.38M	0.05	-$12.34M	-$1.40	N/A
Mannatech	$107.36M	0.11	-$15.21M	-$3.91	N/A

Synergy CHC currently has a consensus price target of $6.25, suggesting a potential upside of 6,168.81%. Given Synergy CHC's stronger consensus rating and higher possible upside, equities research analysts plainly believe Synergy CHC is more favorable than Mannatech.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Synergy CHC	1 Sell rating(s)	1 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.25
Mannatech	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Mannatech has a net margin of -6.90% compared to Synergy CHC's net margin of -60.02%. Synergy CHC's return on equity of 0.00% beat Mannatech's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Synergy CHC	-60.02%	N/A	-30.30%
Mannatech	-6.90%	-2,383.34%	-24.43%

In the previous week, Mannatech had 4 more articles in the media than Synergy CHC. MarketBeat recorded 6 mentions for Mannatech and 2 mentions for Synergy CHC. Synergy CHC's average media sentiment score of 1.94 beat Mannatech's score of 0.18 indicating that Synergy CHC is being referred to more favorably in the media.

Company	Overall Sentiment
Synergy CHC	Very Positive
Mannatech	Neutral

Summary

Synergy CHC and Mannatech tied by winning 8 of the 16 factors compared between the two stocks.

Get Mannatech News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding MTEX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

MTEX vs. The Competition

Export

Metric	Mannatech	Personal Care Products Industry	Consumer Staples Sector	NASDAQ Exchange
Market Cap	$11.87M	$22.60B	$16.13B	$13.10B
Dividend Yield	N/A	4.29%	3.20%	10.45%
P/E Ratio	-1.60	15.46	13.30	25.28
Price / Sales	0.11	12.56	262,280.37	87.62
Price / Cash	N/A	29.73	57.60	50.90
Price / Book	-2.42	2.80	5.06	6.24
Net Income	-$15.21M	$1.08B	$831.83M	$347.60M
7 Day Performance	30.48%	-0.93%	0.57%	1.07%
1 Month Performance	37.06%	0.72%	1.47%	1.03%
1 Year Performance	-36.87%	-15.13%	13.54%	20.77%

Mannatech Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
MTEX Mannatech	1.1768 of 5 stars	$6.25 +1.6%	N/A	-38.4%	$11.87M	$107.36M	N/A	250	News Coverage Earnings Report Gap Down Trading Halted
DSY Big Tree Cloud	1.1931 of 5 stars	$3.58 -5.5%	N/A	-81.1%	$18.01M	$2.56M	N/A	82	Positive News Gap Up
NHTC Natural Health Trends	0.9143 of 5 stars	$1.80 -2.2%	N/A	-59.7%	$15.78M	$39.78M	N/A	140	Positive News
NAII Natural Alternatives International	0.7736 of 5 stars	$2.32 +2.2%	N/A	-42.4%	$14.24M	$129.86M	N/A	290	News Coverage Short Interest Increase Gap Up
DRMA Dermata Therapeutics	2.7292 of 5 stars	$1.11 +3.1%	$10.00 +802.5%	-75.7%	$4.32M	N/A	N/A	8	Earnings Report Gap Down

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:MTEX) was last updated on 8/14/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Mannatech (MTEX) Competitors

MTEX vs. DSY, NHTC, NAII, DRMA, and SNYR

How does Mannatech compare to Big Tree Cloud?

Summary

How does Mannatech compare to Natural Health Trends?

Summary

How does Mannatech compare to Natural Alternatives International?

Summary

How does Mannatech compare to Dermata Therapeutics?

Summary

How does Mannatech compare to Synergy CHC?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

MTEX vs. The Competition

Mannatech Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Mannatech (MTEX) Competitors

MTEX vs. DSY, NHTC, NAII, DRMA, and SNYR

How does Mannatech compare to Big Tree Cloud?

Which has preferable earnings & valuation, DSY or MTEX?

Does the media refer more to DSY or MTEX?

Do institutionals and insiders believe in DSY or MTEX?

Do analysts recommend DSY or MTEX?

Which has more risk & volatility, DSY or MTEX?

Is DSY or MTEX more profitable?

Summary

How does Mannatech compare to Natural Health Trends?

Do institutionals and insiders believe in MTEX or NHTC?

Do analysts recommend MTEX or NHTC?

Is MTEX or NHTC more profitable?

Does the media prefer MTEX or NHTC?

Which has stronger earnings & valuation, MTEX or NHTC?

Which has more volatility and risk, MTEX or NHTC?

Is MTEX or NHTC a better dividend stock?

Summary

How does Mannatech compare to Natural Alternatives International?

Which has stronger earnings & valuation, NAII or MTEX?

Is NAII or MTEX more profitable?

Does the media prefer NAII or MTEX?

Do institutionals & insiders believe in NAII or MTEX?

Which has more volatility and risk, NAII or MTEX?

Do analysts rate NAII or MTEX?

Summary

How does Mannatech compare to Dermata Therapeutics?

Do analysts prefer MTEX or DRMA?

Which has more risk and volatility, MTEX or DRMA?

Which has higher earnings & valuation, MTEX or DRMA?

Is MTEX or DRMA more profitable?

Does the media favor MTEX or DRMA?

Do insiders & institutionals believe in MTEX or DRMA?

Summary

How does Mannatech compare to Synergy CHC?

Do insiders & institutionals hold more shares of SNYR or MTEX?

Which has more volatility and risk, SNYR or MTEX?

Which has higher valuation and earnings, SNYR or MTEX?

Do analysts recommend SNYR or MTEX?

Is SNYR or MTEX more profitable?

Does the media refer more to SNYR or MTEX?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

MTEX vs. The Competition

Mannatech Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools